MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE
Clinical trials for MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE explained in plain language.
Never miss a new study
Get alerted when new MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE trials appear
Sign up with your email to follow new studies for MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough leukemia: Three-Drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs—ziftomenib, venetoclax, and gemtuzumab—in children and young adults (ages 3 to 21) with acute myeloid leukemia that has come back or not responded to treatment. The main goal is to find a safe dose and check for side effec…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New oral cocktail aims to tame tough leukemia
Disease control Recruiting nowThis study tests a new all-oral combination of three drugs—SNDX-5613, ASTX727, and venetoclax—for people with acute myeloid leukemia (AML) or related leukemia. The first part finds the safest dose of SNDX-5613, and the second part checks if that dose helps control the disease. Ab…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA WITH MYELOID PHENOTYPE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC